Behind the Data with Dr. Emily Hollister
In a new series profiling our team of microbiome experts, we have set out to understand microbiome research by asking our bioinformaticians – who have published highly cited papers ranging from topics on paleomicrobiology to semi-industrial profiling of the microbiome. Our bioinformaticians are experts in the human microbiome at birth and in disease states. They have even discovered […]
Validation of Diversigen’s viral metagenomics sequencing and analysis pipeline for SARS-CoV-2 detection
Below we’re sharing results from the validation study scientists at Diversigen and DNA Genotek undertook to ensure Diversigen’s viral metagenomics capabilities could be leveraged to help during the COVID-19 pandemic. “When I was a boy and I would see scary things in the news, my mother would say to me, “Look for the helpers. You […]
Validation of our viral metagenomics sequencing and analysis pipeline for SARS-CoV-2 detection
In this article we’re sharing results from the validation study scientists at Diversigen and DNA Genotek undertook to ensure Diversigen’s viral metagenomics capabilities could be leveraged to help during the COVID-19 pandemic. When I was a boy and I would see scary things in the news, my mother would say to me, “Look for the […]
Industry leaders Diversigen and CoreBiome come together to support microbiome discovery
As the microbiome industry grows and evolves, so has our team of microbiome experts. In 2019, DNA Genotek’s parent company, OraSure, acquired both CoreBiome and Diversigen. Through these acquisitions, we gained Diversigen’s industry recognized CLIA/CAP state-of-the-art techniques with expert consultative microbiome services, and the strength of CoreBiome’s innovative scalable sequencing technology. In this podcast, Lisa Gamwell, Services […]
Strategies in microbiome sequencing
Strategies in microbiome sequencing By Shanda Giacomoni on Jan 16, 2020 1:15:00 PM Choosing the best sequencing platform for your research There are many ways to profile a microbiome: Amplicon (16S) sequencing, shallow shotgun or deep shotgun. Each platform has its own strengths and limitations that can influence your study design. Dr. Tonya Ward, CoreBiome’s Data Science Manager, […]
Standardization in microbiome measurements: considerations from sampling to analysis
UPDATE: On May 12, 2020, CoreBiome rebranded as Diversigen Inc. From sample collection to analysis, the ability to snapshot the microbial community and accurately analyze the results is key to the success of any study. To accomplish these feats, accurate and reproducible protocols for sample collection, DNA extraction, sequencing methodology and data interpretation are required. […]
Diversigen bioinformatics team publishes review on the human virome and disease
“The virome is comprised of endogenous retroviruses, eukaryotic viruses, and bacteriophages and is increasingly being recognized as an essential part of the human microbiome. The human virome is associated with Type-1 diabetes (T1D), Type-2 diabetes (T2D), Inflammatory Bowel Disease (IBD), Human Immunodeficiency Virus (HIV) infection, and cancer. Increasing evidence also supports trans-kingdom interactions of viruses […]
“Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases”
“Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are heterogeneous at the clinical, immunological, molecular, genetic, and microbial levels.” Read More
A look ahead for the microbiome industry: An interview with Dr. Dan Knights
UPDATE: On May 12, 2020, CoreBiome rebranded as Diversigen Inc. We recently introduced readers of The Microbiome Snapshot to our sister company, CoreBiome, a privately-held, Minnesota-based microbiome analysis company that accelerates discovery for customers in the pharmaceutical, agricultural, environmental and research communities. We are continuing this story via a podcast with CoreBiome co-founder, Dr. Dan Knights. In […]
